HEART & LUNG is a premier academic journal published by MOSBY-ELSEVIER, focusing on the critical intersections of cardiology, critical care, and respiratory medicine. Since its inception in 1973, the journal has established a significant reputation within the medical community, as evidenced by its impressive Q2 ranking in key categories such as Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine, and Pulmonary and Respiratory Medicine for the year 2023. With a dedicated readership comprising researchers, healthcare professionals, and students, HEART & LUNG serves as a vital platform for disseminating cutting-edge research, clinical innovations, and comprehensive reviews that influence practice standards and enhance patient care. While it currently does not offer Open Access options, readers can access a wealth of information pivotal to the advancement of medical knowledge and practice through conventional subscription. Explore the latest findings and contribute to the ever-evolving landscape of cardiovascular and respiratory health through this esteemed journal.

ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.

Respiratory Care is a leading journal in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, published by DAEDALUS ENTERPRISES INC. With a history dating back to 1973 and continuing through 2024, this journal serves as a vital platform for disseminating innovative research findings, clinical practices, and advancements in respiratory healthcare. The journal is recognized for its impact, reflected in its impressive Q2 quartile rankings across several categories in 2023, demonstrating its relevance and influence in the medical community. Although it is not an Open Access publication, it provides critical insights and foster discussions aimed at enhancing patient care and treatment protocols for respiratory diseases. The journal is indexed in notable databases, ensuring wide visibility and accessibility of its content to researchers, professionals, and students dedicated to advancing knowledge and practice in respiratory care.

The Journal of Intensive Care, published by BMC, is a leading open access journal dedicated to advancing research and knowledge in the fields of critical care and intensive care medicine. With an impressive 2023 rank of #11 out of 110 in its category and placing in the 90th percentile, this journal offers a vital platform for researchers, clinicians, and healthcare professionals to disseminate innovative findings and best practices. Launched in 2013, the journal has gained significant recognition, achieving a Q1 quartile ranking in critical care, reflecting its commitment to high-quality contributions that address pressing issues in patient management and care. Additionally, as an open access publication, the journal ensures that its content is widely accessible, fostering collaboration and knowledge sharing within the global medical community. For those engaged in intensive care, the Journal of Intensive Care is an essential resource for staying abreast of the latest research trends and clinical advancements.

Sarcoidosis Vascularitis and Diffuse Lung Diseases is a prestigious academic journal published by Mattioli 1885, focusing on the interdisciplinary study of sarcoidosis, vasculitis, and various diffuse lung diseases. Since its inception in 1996, this journal has been pivotal in disseminating vital research findings, clinical experiences, and comprehensive reviews related to these complex conditions, supporting health professionals and researchers in advancing their understanding and treatment approaches. With a convergence period extending to 2024, the journal has gained recognition in multiple categories, including Q4 in Immunology and Allergy, and Q3 rankings in Internal Medicine, Medicine (Miscellaneous), and Pulmonary and Respiratory Medicine, reflecting its commitment to high-quality and impactful studies. Although currently not offering open access, its contributions are indispensable for the academic community, making it a vital resource for those dedicated to improving patient outcomes and fostering knowledge in the field.

Anaesthesiology Intensive Therapy is a prestigious open-access journal published by TERMEDIA PUBLISHING HOUSE LTD, dedicated to advancing knowledge in the fields of anaesthesiology, critical care, and intensive medicine. Since its establishment in 2012, the journal has provided a vital platform for researchers, practitioners, and students to disseminate innovative findings, case studies, and reviews that contribute to the evolution of clinical practices and methodologies within these critical fields. With an impact factor that places it in the second quartile of its categories in Anesthesiology and Pain Medicine and Critical Care and Intensive Care Medicine, and a respectable ranking in the related areas, the journal has carved out a significant niche for itself in the global academic landscape. Accessible freely to all since its inception, Anaesthesiology Intensive Therapy facilitates unrestricted dissemination of research outputs, promoting collaborative exchanges and ensuring that contemporary advancements reach a broad audience of healthcare professionals. With its international scope and rigorous peer-review process, the journal stands as a beacon of quality scholarship, tirelessly working to enhance patient care and outcomes.

Intensive Care Medicine Experimental is a premier open-access journal dedicated to advancing research and clinical practice within the realms of critical care, intensive care medicine, and emergency medicine. Published by SPRINGER, this influential journal has been committed to dispensing high-quality, peer-reviewed research since its inception in 2013, reflecting its progressive approach to open-access publishing and enhancing global accessibility to vital medical information. With a notable impact factor and categorically established Q1 rankings in both Critical Care and Emergency Medicine, as well as Q2 in Physiology (medical), the journal underscores its significance in disseminating groundbreaking studies and innovations. Positioned prominently within the medical literature, Intensive Care Medicine Experimental ranks 16th in Emergency Medicine and 27th in Critical Care, providing a vital platform for researchers, clinicians, and students alike to explore and share cutting-edge research findings that aim to improve patient outcomes. The journal's dedication to fostering collaboration and dialogue among professionals makes it an essential resource in the evolving landscape of intensive care and emergency medical disciplines.

HEART FAILURE REVIEWS is a premier academic journal published by Springer, dedicated to the dynamic field of cardiology and cardiovascular medicine. With an impressive Q1 ranking in 2023, the journal stands as a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments in heart failure management and research. Covering a broad spectrum of topics, including innovative therapies, epidemiology, and pathophysiology of heart failure, it fosters an environment for interdisciplinary collaboration. The journal is indexed with an ISSN of 1382-4147 and an E-ISSN of 1573-7322, ensuring widespread dissemination of knowledge. Although it does not currently offer open access options, its rigorous peer-review process guarantees high-quality content that contributes significantly to the scientific community. Established in 1996 and running through 2024, HEART FAILURE REVIEWS continues to be a leading platform for advancing understanding and treatment of heart conditions, making it an indispensable resource for all stakeholders in cardiac health.

Signa Vitae is a distinguished academic journal published by MRE PRESS, focusing on critical care, intensive care medicine, and emergency medicine. Established in 2008 and running through 2024, this journal serves as an essential conduit for the dissemination of innovative research and clinical practices in these dynamic fields. Based in Croatia, Signa Vitae is indexed in Scopus, highlighting its importance within the scholarly community, boasting respectable quartiles with a Q3 ranking in both Critical Care and Intensive Care Medicine and Emergency Medicine as of 2023. Although it operates under a traditional access model, the journal aims to enhance knowledge sharing and interdisciplinary dialogue among researchers, healthcare professionals, and students globally, addressing the urgent challenges and advancements in patient care. By providing a platform for high-quality studies and reviews, Signa Vitae continues to advance the conversation and practice within critical and emergency medicine.

CRITICAL CARE MEDICINE is a premier journal dedicated to the advancement of knowledge and practice in the field of critical care and intensive care medicine. Published by Lippincott Williams & Wilkins, this distinguished journal has been at the forefront of medical research since its inception in 1973, and it continues to offer insights into the latest developments and innovations in critical care. With a remarkable ranking of #5 out of 110 in Scopus' Critical Care category and a 95th percentile rating, CRITICAL CARE MEDICINE is a leading source for high-impact research, reviews, and clinical studies. The journal is recognized as a Q1 publication, underscoring its authoritative presence within the academic community. Researchers and clinicians are encouraged to engage with cutting-edge findings that aim to improve patient care and outcomes. Although the journal is not open access, it remains an essential resource for professionals seeking to enhance their understanding and application of critical care practices.